Otsuka Holdings Co., Ltd. (FRA:OS1)
Germany flag Germany · Delayed Price · Currency is EUR
41.40
+0.60 (1.47%)
Last updated: May 13, 2025
6.70%
Market Cap 22.01B
Revenue (ttm) 14.79B
Net Income (ttm) 2.17B
Shares Out n/a
EPS (ttm) 4.01
PE Ratio 10.16
Forward PE n/a
Dividend 0.71 (1.65%)
Ex-Dividend Date Jun 27, 2025
Volume n/a
Average Volume 50
Open 41.60
Previous Close 40.80
Day's Range 41.20 - 41.60
52-Week Range 35.40 - 59.00
Beta n/a
RSI 40.60
Earnings Date Apr 30, 2025

About Otsuka Holdings

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutr... [Read more]

Industry Pharmaceutical Preparations
Founded 1921
Employees 35,338
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol OS1
Full Company Profile

Financial Performance

In 2024, Otsuka Holdings's revenue was 2.33 trillion, an increase of 15.42% compared to the previous year's 2.02 trillion. Earnings were 343.12 billion, an increase of 182.13%.

Financial numbers in JPY Financial Statements

News

There is no news available yet.